MRI-Guided Adaptive Radiation Therapy for Organ Preservation in Rectal Cancer

NCT04808323 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

22

Enrollment

OTHER

Sponsor class

Conditions

Rectal Adenocarcinoma

Interventions

DRUG: Capecitabine
DEVICE: Initial Dose of Radiation before Dose Escalation
DEVICE: Cohort A: Dose Escalation Radiation
DEVICE: Cohort B: Dose Escalation Radiation
DEVICE: Cohort C: Dose Escalation Radiation
DRUG: FOLFOX

Sponsor

Medical College of Wisconsin